Genetic Polymorphisms Associated with Prothrombin Time and Activated Partial Thromboplastin Time in Chinese Healthy Population

Genetic Polymorphisms Associated with Prothrombin Time and Activated Partial Thromboplastin Time in Chinese Healthy Population

(1) Background: The purpose of this study was to evaluate the effect of gene polymorphisms on prothrombin time (PT) and activated partial thromboplastin time (APTT) in a healthy Chinese population. (2) Methods: A total of 403 healthy volunteers from a series of novel oral anticoagulants (NOACs) bioe...

Full description

Bibliographic Details
Main Authors:	Fan Zhang, Guangyan Mu, Zhiyan Liu, Qiufen Xie, Hanxu Zhang, Shuang Zhou, Zhe Wang, Kun Hu, Zining Wang, Xia Zhao, Yimin Cui, Qian Xiang
Format:	Article
Language:	English
Published:	MDPI AG 2022-10-01
Series:	Genes
Subjects:	activated partial thromboplastin time (APTT) genome-wide association analysis healthy population prothrombin time (PT) whole-exome sequencing
Online Access:	https://www.mdpi.com/2073-4425/13/10/1867

Similar Items

Prothrombin time and activated partial thromboplastin time in women with gestational diabetes mellitus
by: Samira Mahjabeen, et al.
Published: (2023-01-01)

Effect of plasma storage on prothrombin time and activated partial thromboplastin time at a Nigerian public laboratory
by: Mohammed A Ndakotsu, et al.
Published: (2013-01-01)

Variations in activated partial thromboplastin time and prothrombin time in individuals of A, B, AB, and O blood groups
by: Chizoba Okechukwu Okeke, et al.
Published: (2018-01-01)

Effect of Haemodialysis on Mean Prothrombin Time and Activated Partial Thromboplastin Time in Patients of End Stage Renal Disease
by: Attika Khalid
Published: (2015-12-01)

The Influence of Sustained Mercury Exposure on Prothrombin Time and Partial Thromboplastin Time among Sudanese Gold Mining Workers
by: Rimonda Emil Tadros, et al.
Published: (2022-06-01)

Unified Methodology for the Primary Preclinical In Vivo Screening of New Anticoagulant Pharmaceutical Agents from Hematophagous Organisms
by: Maria A. Kostromina, et al.
Published: (2024-04-01)

Treatment modality, diabetic control and blood homeostasis in type 2 diabetes mellitus patients in Basra
by: Kadhim Sheima N., et al.
Published: (2021-06-01)

Prediction of Poor Outcomes in Patients with Colorectal Cancer: Elevated Preoperative Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT)
by: Zhang L, et al.
Published: (2020-07-01)

Analisis Nilai Clothing Time, Prothrombine Time dan Activated Partial Thromboplastine Time pada Remaja Obes
by: Nelly Nelly, et al.
Published: (2019-03-01)

Prothrombine and activated partial thromboplastin time are prolonged in hepatic cirrhosis
by: Edward Kurnia Setiawan Limijadi, et al.
Published: (2016-05-01)

Standardization of Coagulation Factor V Reference Intervals, Prothrombin Time, and Activated Partial Thromboplastin Time in Mice for Use in Factor V Deficiency Pathological Models
by: Juan A. De Pablo-Moreno, et al.
Published: (2022-03-01)

Effect of anticoagulant adjustment on prothrombin time test using two different PT reagents in patients with elevated hematocrit
by: Vanessa M. Silva, et al.
Published: (2020-11-01)

Determination of prothrombin time and activated partial thromboplastin time in newly diagnosed untreated cases of type-2 diabetes mellitus at the University of Nigeria teaching hospital, Enugu
by: E O Ukaejiofo, et al.
Published: (2007-01-01)

Analysis of D-Dimer Level and Prothombin Time (PT) Activated Prothombin Thromboplastin (APTT) on Heparin Administration to COVID-19 Patients
by: Dela Yorike, et al.
Published: (2022-04-01)

Within- and between-subject biological variation of hemostasis parameters in a study of 26 healthy individuals
by: Zengi Oguzhan, et al.
Published: (2023-08-01)

Effect of oral vitamin K prophylaxis on prothrombine time and activated partial thromboplastin time: a randomized controlled comparison with an intramuscular vitamin K in infants
by: V. Lily Limantara, et al.
Published: (2007-07-01)

Evaluation of Prothrombin Time,International Normalized Ratio, and Activated Partial Thromboplastin Time in Hepatitis B Virus Patients, Sudan2020 -2021
by: GadAllah Modawe, et al.
Published: (2024-01-01)

Isolated Prolongation of Activated Partial Thromboplastin Time: Not Just Bleeding Risk!
by: Rita Carlotta Santoro, et al.
Published: (2023-06-01)

Prothrombin Time-International Normalized Ratio Predicts the Outcome of Atrial Fibrillation Patients Taking Rivaroxaban
by: Tze-Fan Chao, et al.
Published: (2022-12-01)

Impact of Polyethylene Glycol Functionalization of Graphene Oxide on Anticoagulation and Haemolytic Properties of Human Blood
by: Trayana Kamenska, et al.
Published: (2021-08-01)

Plasma prothrombin time and activated partial thromboplastin time as predictors of bleeding manifestations during dengue hemorrhagic fever
by: I. N. Budastra, et al.
Published: (2009-04-01)

The frequency and timing of sepsis-associated coagulopathy in the neonatal intensive care unit
by: Khyzer B. Aziz, et al.
Published: (2024-03-01)

Avaliação do desempenho dos reagentes do tempo de tromboplastina parcial ativada utilizados para detectar o anticoagulante lúpico Assessment of the performance of reagents of activated partial thromboplastin time used to detect the lupus anticoagulant
by: Fernanda Chiuso, et al.
Published: (2005-06-01)

STANDARDIZATION OF PROTHROMBIN TIME TEST AND EVALUATION OF QUALITY OF PATIENT MANAGEMENT WITH WARFARIN
by: A.H ZARGARZADEH, et al.
Published: (2000-12-01)

The effect of vitamin K on prothrombin time in critically ill patients: an observational registry study
by: Sofia Dahlberg, et al.
Published: (2021-01-01)

Potential Anticoagulant Activity of Thymus atlanticus Leaves Part in vitro on Normal Plasma Samples
by: Mothana Abdullah Elhussein, et al.
Published: (2022-06-01)

Biological evaluation of the effect of sugammadex on hemostasis and bleeding
by: Julien Raft, et al.
Published: (2015-02-01)

The changes in the fibrinogen concentration and coagulation pathways in winter and summer in cattle
by: ameneh khoshvaghti
Published: (2013-08-01)

Prothrombin time in retinitis pigmentosa
by: Vinchurkar Manisha
Published: (1998-01-01)

Green tea consumption effects on coagulation profile
by: Ahmed Mohammed Elnour Elkhalifa, et al.
Published: (2020-01-01)

Hemostatic abnormalities in children with thalassemia major and liver iron overload
by: Pustika Amalia Wahidiyat, et al.
Published: (2018-08-01)

Evaluation of anticoagulant and thrombolytic activity of Berberis orthobotrys in animal model
by: . Alamgeer, et al.
Published: (2018-06-01)

Establishing reference ranges and normal values for coagulation screening in healthy Indian male volunteers enrolled for a longitudinal study
by: Rehan Ahmed, et al.
Published: (2019-01-01)

A note on the prothrombin time abnormality in the patients with amebic liver abscess
by: Viroj Wiwaniikit, et al.
Published: (2006-12-01)

Evaluation of Antiphospholipid Antibodies and Activated Partial Thromboplastin Time in Women with Adverse Outcome of Pregnancy
by: Sariyeh Golmahammad lou, et al.
Published: (2010-12-01)

Coagulation profile alterations in dogs co-infected with visceral leishmaniasis and monocytic ehrlichiosis
by: Canberk BALIKÇI, et al.
Published: (2023-09-01)

Evaluation of Prothrombin Time in Acute Acetaminophen Overdose treated by N-acetylcysteine
by: Babak Mostafazadeh, et al.
Published: (2016-02-01)

The Effect of 8-Weeks Exercise in Water on Factor VIII and Partial Thromboplastin Time (PTT) of Men with Hemophilia
by: Marziyeh Soltani, et al.
Published: (2016-01-01)

Replacement of traditional prothrombin time monitoring with the new Fiix prothrombin time increases the efficacy of warfarin without increasing bleeding. A review article
by: Pall T. Onundarson, et al.
Published: (2021-10-01)

Evolving Paradigm of Prothrombin Time Diagnostics with Its Growing Clinical Relevance towards Cardio-Compromised and COVID-19 Affected Population
by: Anubhuti Saha, et al.
Published: (2021-04-01)